Top 50 Medical VC Funds in Germany
A list of 50 VC funds that invest in Medical startups based in Germany. We rank investors based on the number of investments they made in Medical companies from Germany. We update this investor list every month.Top 50 Medical VC Funds in Germany
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- TRAIT — TRAIT Running Coach app for your iphone or ipad tablet.
- Heidelberg Epignostix — Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts. Heidelberg Epignostix has revolutionized tumor categorization by using the strength of methylation-based algorithms.
- InSpacePropulsion Technologies — ISPTech is a Spin-Off of the Institute of Space Propulsion at the German Aerospace Center (DLR). It offers non-toxic, green propulsion solutions
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Funding Round
- Germany, United States, Finland
Portfolio highlights
- planqc — planqc quantum computers store information in individual atoms – nature's best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc unique combination of quantum technologies is the fastest way to scale to thousands of qubits, aprerequisite for industry-relevant quantum advantage.
- Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
- Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Funding Round, Series A, Series B
- Germany, India, Kenya
Portfolio highlights
- Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
- Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
- Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Germany, France, Austria
Portfolio highlights
- HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
- Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more
Investment focus
- Biotechnology, Software, Information Technology
- Seed, Series A, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- widu — widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace
- Black Semiconductor — Black Semiconductor manufacture microchips with integrated electronic-photonic circuits using graphene technology.
- Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Funding Round
- Germany, United States, United Kingdom
Portfolio highlights
- UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
- Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
- Onward — Working to restore movement, independence, and health in people with spinal cord injury.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Orus Energy — Orus Energy leverages the power of AI to unlock potential of electrical flexibility in commercial buildings.
- SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Switzerland, Germany, France
Portfolio highlights
- Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States
Portfolio highlights
- MiViA — From microstructure segmentation to grain size measurement! Our AI engine provides a fast and reliable metallographic analysis for metallic products.}
- Packwise — Packwise is bringing Intermediate Bulk Containers (IBCs) to the Internet of Things. Their Packwise Smart Cap makes a container intelligent and allows for improved and automated packaging management and logistics. Millions of IBCs are being used by chemical, pharmaceutical and food companies every day. Their Packwise Smart Cap is narrow-band LPWANconnected and provides users with real-time information on the state and location of containers.Packwise develops ready-to-use web applications and can be integrated with existing in-house IT or software through web service API.Packwise GmbH is a German company based in the Silicon Saxony. Packwise is Europe’s pioneer in digital industrial packaging management (IBCs and drums).
- watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more
Investment focus
- Financial Services, FinTech, Software
- Seed, Series A, Pre-Seed
- Germany, United States, United Kingdom
Portfolio highlights
- Alvys — Alvys is a cloud-based transportation management system with high-tech automation. Specializing in workflow efficiency for small to mid-size carriers. Alvys stands out by saving carriers and freight brokers more time per load than any other TMS! Save up to 30 minutes per load, organize your operations in one place, scale with ease and integrateall your favorite tools. The proof is in the workflows and here's a sneak peek of our popular features:• Driver App • Tracking & Tracing • Source for Truck Capacity • End-to-End Visibility • One Click Accounting • Analytics & Reporting • Safety & Maintenance • Integrations • Benefits for BrokersTRY US FOR FREE! www.alvys.com
- Hive — Fulfillment with Hive means 100% peace of mind at up to 30% cost savings. Move your operations to Hive now.
- Niva — Niva's business identity platform enables institutions across the globe to verify more businesses faster, safer, and smarter with AI. Scale your fraud and compliance teams with Niva.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more
Investment focus
- Health Care, Wellness, Software
- Seed, Pre-Seed, Series A
- Germany, United Kingdom, Austria
Portfolio highlights
- Scavenger AI — Generative AI and Data Analytics for your daily business challenges. Scavenger uses Artificial Intelligence and Machine Learning Algorithms to power its 3 tools: Purity, Quantum and Prophecy. Purity cleans and harmonizes the data. Quantum runs statistical algorithms and analyzes the data. Prophecy d
- Meela — Meela AB matches individuals with psychologists or psychotherapists for online and in-person therapy.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Funding Round, Series A
- Germany, United States, United Kingdom
Portfolio highlights
- Quantistry — Revolutionize your R&D with QuantistryLab. Explore 100 million structures and run your own simulations from Quantum to AI. Get started today!
- Elucid Social — Elucid Social integrates businesses with the social good movement through a data-driven strategy that yields measurable results. Elucid Social develops and deploys technologies to assess, report, and minimize human rights risks linked with the sourcing of products and services.
- Northbound — We are building the dynamic decision engine that translates real-time data into operational excellence & stakeholder transparency. All at the intersection of warehouse and transport logistics.
We support exceptional founders in building market leading digital companies.
Show more
Investment focus
- E-Commerce, Internet, Software
- Series A, Seed, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
- Storyblok — Storyblok is an intuitive content management system that helps your developer and marketing teams get value from your content faster and create innovative digital experiences.
- Bioniq — Bioniq offers a data-driven approach to disease prevention and health promotion. To do this, the company has created a digital platform that aggregates and analyzes data from blood tests, genetic tests and microbiota tests using AI over time.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Pre-Seed, Series A
- Germany, Australia, United States
Portfolio highlights
- Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
- Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
- InSpacePropulsion Technologies — ISPTech is a Spin-Off of the Institute of Space Propulsion at the German Aerospace Center (DLR). It offers non-toxic, green propulsion solutions
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Funding Round, Series A
- Germany, United States
Portfolio highlights
- rooom.com — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
- tediro — tediro develops a mobile robotics platform for multiple applications in healthcare primarily therapy and diagnostics
- Coachwhisperer — Coachwhisperer: The live communication system for sports. We take training to the next level and help coaches and athletes reach their true potential.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Pre-Seed
- Germany, Switzerland, United States
Portfolio highlights
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
- SynthFlow AI — Forget lengthy development cycles and expensive machine learning teams. With Synthflow you can build sophisticated, tailored AI agents without technical skills or coding - just bring your data and ideas.
- SCRYPT Digital — Your trusted partner for crypto assets
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more
Investment focus
- Software, E-Commerce, Internet
- Seed, Series A, Pre-Seed
- Germany, United States, Poland
Portfolio highlights
- NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Akhetonics — Creating the first all-optical RISC Processor
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
- Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Germany, United Kingdom
Portfolio highlights
- Dryad Networks — Overview of Dryad, providing ultra-early fire detection as well as forest growth and health monitoring.
- Mateo — Mateo is the omni-channel customer experience powerhouse that empowers local brands and businesses to drive growth through a digital customer lifecycle management. From acquiring new leads, converting them into customers and extending those relationships - all in one platform.
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more
Investment focus
- Software, SaaS, Health Care
- Seed, Pre-Seed, Series A
- Germany, Austria, Switzerland
Portfolio highlights
- mogenius — mogenius radically simplifies cloud infrastructure for software developers. The code to cloud platform provides a completely automated workflow of deploying an application in Kubernetes - with hyperscale cloud resources, built-in CI/CD and DDoS protection so you can start coding in seconds. Never waste time on complicated, error-prone, andrepetitive configurations in your cloud infrastructure again, and focus on what you really love: building great applications.
- happyhotel — The happyhotel revenue and yield management system has a simple dashboard that supports the hotelier in the data analysis of the most important hotel KPI’s. happyhotel is a cloud-based hotel software specially designed for small and medium-sized hotels. Hoteliers can achieve more revenue without a great deal of prior knowledge. The hotelier getpast, current and future values of RevPar, Occupancy, ADR and Revenue. Through the booking pace graph and the on the books evaluation the hotelier can react to the current market conditions. Furthermore the hotelier can review every day the important reports and get an alert if the values do not correspond with the budget. happyhotel use a special formula and an algorithm who gives the hotelier the best price recommendation for his hotel or each of your hotel segments and room types. With an interface to the hotel pms happyhotel get all data to analyze the hotel. happyhotel facilitates the hotelier's life through automatic processes so that he can concentrate on other things.
- Helio — Carbon Aware Cloud Computing.
Investing early in Europe's most passionate founders.
Show more
Investment focus
- Health Care, Financial Services, Software
- Seed, Series A, Funding Round
- Germany, Austria, United Kingdom
Portfolio highlights
- LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
- OneTwenty — OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes.
- HealthCaters — HealthCaters is a connected care solution for companies that allows them to empower their employees to take control of their health.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
- Sodex Innovations — Sodex Innovations is a company which is specialized in developing assistance-systems and automating-kits for excavators
Vorwerk Ventures is an independent €150m Venture Capital Fund grown out of the Vorwerk Group in late 2019 and defines itself through a strong commitment towards consumer-facing digital businesses. Our unique direct selling experience in addition to an outstanding track record in Venture Capital provides added value for forward-thinkingentrepreneurs. Headquartered in Berlin Germany, we currently have more than €250m in assets under management and are constantly on the look-out for promising opportunities starting with Seed/Series A investments of €1m to €10m and ensuring continuous support reserving up to €15m for upcoming financing rounds. An outstanding founding team, an existing market presence and a well-defined exit strategy framed by a consumer-centric business model are key requirements to us when it comes to making an investment decision.
Show more
Investment focus
- E-Commerce, Health Care, Food and Beverage
- Seed, Series A, Series B
- Germany, United Kingdom, Switzerland
Portfolio highlights
- Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
- CarbonPool — Innovative carbon credit insurance which pays claims in carbon credits, not cash. See how we can help you.
- Sorella Care — Sorella is the first network of multidisciplinary health places for women. Sorella ensures that every woman, regardless of age, has access to a comprehensive care pathway offered by women's health specialists.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
- Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
- Progentos Therapeutics — Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more
Investment focus
- Medical, Shopping, E-Commerce
- Seed, Series A, Series C
- Germany, United States
Portfolio highlights
- ShopCo Technologies — Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.
- NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
- Dynamic42 — Dynamic42 provides, customizes innovative 3D microphysiological in vitro test systems recreating human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for preclinical research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems.
Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.
Show more
Investment focus
- Medical, Therapeutics, Biotechnology
- Series A, Series B, Funding Round
- Germany
Portfolio highlights
- Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
- Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
UNIQA Ventures GmbH is the Venture Capital arm of UNIQA Insurance Group AG, a leading insurance carrier in Central & Eastern Europe and a pioneer in Corporate-backed Venture Capital in Austria and CEE. Based in Vienna, Austria, the firm is investing in outstanding business models driven by strong teams and a clear vision to shape the future ofkey industries. Investment areas are the future of Health, Mobility, Intelligent Home and FinTech/InsurTech as well as enabling technologies such as IoT, Blockchain, ML/AI.
Show more
Investment focus
- Insurance, Health Care, FinTech
- Series A, Seed, Series B
- Austria, Germany, United Kingdom
Portfolio highlights
- ifeel — Ifeel is the emotional well-being platform for modern organizations. Ifeel is a unique workplace mental health platform for companies.
- goUrban — goUrban offers mobility solutions for sharing operators and B2B fleet management. The way of transportation and mobility is changing rapidly. For operating smarter and using the opportunities of the sharing economy we provide you our fleet management OS.
- doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.
Playground is an early-stage investment firm that helps old and new investors and entrepreneurs working at the intersection of bits, atoms, and AI. It focuses on investment, innovation, connected hardware, artificial intelligence, and robotics.
Show more
Investment focus
- Software, Robotics, Artificial Intelligence
- Series A, Seed, Series B
- United States, Canada, France
Portfolio highlights
- Boxbot — Dynamic storage and retrieval platform that adapts to varying cubic dimensions and eliminates manual pick stations.
- Insamo — Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
- Element Zero — Element Zero - The Green Metal Company. Element Zero has developed a novel approach to cost-effectively and efficiently convert metal ores such as iron ore, nickel ore and other future facing metals, to pure metal form with zero carbon emissions.
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more
Investment focus
- Software, Health Care, Medical
- Seed, Series A, Series B
- Germany, Finland, United States
Portfolio highlights
- Semorai — Semorai - Engineering AI
- Doinstruct — Doinstruct offers mobile training solution for frontline workers.
- traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- Belgium, Germany, The Netherlands
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- inHEART — inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become aworldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Series A, Series B
- Germany, Italy, United States
Portfolio highlights
- memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
- StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
- Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.
The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Series B, Series A, Seed
- Germany, Israel, Malaysia
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- Phare Health — We build AI tools to improve the financial health of hospitals, so they can focus on the health of patients.
- QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more
Investment focus
- Software, Internet, Information Technology
- Seed, Series A, Funding Round
- Germany, United States, France
Portfolio highlights
- Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
- Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
- THE CLIMATE CHOICE — The software platform for decarbonizing companies and their supply chains.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
- Software, Information Technology, SaaS
- Pre-Seed, Seed, Series A
- Singapore, United Kingdom, Australia
Portfolio highlights
- Immibot — Get assistance from our AI-powered chatbot on your immigration journey. Our model is trained on official regulations to answer any questions you may have on how to move abroad.
- Quench.ai — Quench is a tech infrastructure for video creators to deliver exclusive content, engage and reward their true fans.
- Source — Source is an AI-powered recruitment platform that makes tech talent sourcing fast, precise, and cost-effective.
Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH
Show more
Investment focus
- Software, EdTech, Medical
- Seed, Pre-Seed, Series A
- Germany
Portfolio highlights
- Gyde — Gyde offers digital micro-learning and cross-company coaching for managers.
- VISPA — Your virtual unlimited space for innovation projects, workshop facilitation, and agile meetings. With more than 30 available pre-built templates.
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups - according to their personal investment focus.
A cooperation with EITHealth, and a growing network of partnerships across Europe, allow Aescuvest to source and evaluate the most promising healthcare investment opportunities, structure their financing rounds, and enable healthcare technology-driven investors, such as Business Angels, HNWIs, Family Offices, and Corporate Investors, to participate in healthcare investment opportunities by direct investments via SPV structures.
The Investment Committee, composed of Aescuvest’s very own investment team and members of tthe Advisory Board of Aescuvest, both deeply rooted in the healthcare industry and with proven track records, have developed a strong and over the last years well tested, pre-screening and due diligence process, to identify and select healthcare start-ups. Aescuvest’’s Management (circle of General Partners) put their ‘skin’ into each investment by committing capital to each company prior introduction to the wider Aescuvest investor base.
The combination of innovative ways for equity capital provision, with healthcare industry and investment expertise, provides the Aescuvest portfolio companies a unique platform to develop their business solution, accelerate their path towards commercialization, and lower market access barriers.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Equity Crowdfunding, Seed, Pre-Seed
- Germany, The Netherlands
Portfolio highlights
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Wachstumsfonds Bayern is a venture capital fund that provides equity capital for growth financing to SMEs.It serves private venture capital companies as a neutral co-investment partner for growth financing. The fund's financing enables innovative start-ups to receive more and larger funding, helping them take further growth steps, such asentering new sales markets. It is open to open to innovative, technology, and growth-oriented companies in all industries, regardless of whether external investors are already involved. A general requirement for participation by the BWachstumsfonds Bayern is that the technology company has a successful business model, has successfully completed the seed phase, and the first startup phase and wants to expand. The successfully completed seed and first startup phase may have been financed by external investors or by the founder/cash flow.The firm was founded in München, Bayern.
Show more
Investment focus
- Medical, Biotechnology, Software
- Series B, Funding Round, Series A
- Germany
Portfolio highlights
- enmacc — The enmacc OTC platform is a energy trading platform for the future of the global energy markets. We are building a next-generation trading platform, powered digital RFQ technology, that will help you to trade smarter, faster and better.
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- iThera Medical — Due to its spatiotemporal resolution, penetration depth, sensitivity and specificity, optoacoustic imaging (OAI) can be used for a multitude of applications.
Capacura is reinventing the venture capital market so that more start-ups get access to capital, knowledge, processes and solutions.
Show more
Investment focus
- EdTech, Mobile, Medical
- Seed, Pre-Seed, Series A
- Germany
Portfolio highlights
- cabuu — cabuu creates scalable interactive educational content for simple fact learning
- hey circle — Hey Circle is a manufacturer of reusable shipping packaging. Hey Circle products include foldable, weather and dirt-resistant shipping bags and reused shipping boxes with theft protection and branding possibilities for brands, offering customers with a sustainable solution that is simple to use for packers and customers.
- Meter friends — Meter friends produces intelligent measuring systems (smart meters) and helps save energy.
German Federal Ministry of Education and Research (BMBF)
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Grant, Seed, Series B
- Germany, United States, Denmark
Portfolio highlights
- InflaRx — InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application.In April 2018, InflaRx conducted a USD 117 million totalgross proceeds follow-on transaction on the US Nasdaq global select market comprised of a primary component of USD 63 million investment into InflaRx as well as a secondary component of USD 54 million to existing first-day shareholders of InflaRx. InflaRx was founded in December 2017 and is headquartered in Jena, Germany.
- Evotec — Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in form of fee-for-service work, integrated drug discovery alliances,development partnerships, licensing of innovative drug candidates, and consulting arrangements. The company operates worldwide and has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in the areas of neuroscience, diabetes, and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases, and fibrosis. By leveraging this expertise, Evotec intends to develop best-in-class and first-in-class differentiated therapeutics on its systematic, unbiased, and comprehensive infrastructure.Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB, and others. In addition, the company has existing development partnerships and product candidates both in clinical and pre-clinical development. These include partnerships with Sanofi in the field of diabetes and cancer immunotherapy, with Pfizer in the field of tissue fibrosis, with Bayer in the field of kidney diseases, and with Celgene in the field of neurodegenerative diseases.
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance,advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective.
The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series C, Series A, Series B
- United States, Germany, Denmark
Portfolio highlights
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
- Coapt Systems — Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilizationtrays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.
- Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
MBG Baden Wuerttemberg is an investment company that helps small and medium sized companies strengthen their capital base.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Series B
- Germany
Portfolio highlights
- Idana — Mit Idana befragen Sie Patient:innen vorab digital. Entlasten Sie Ihr Team und begeistern Sie Ihre Patient:innen.
- stimOS — Smart implants made in Germany and ISO 13485:2016 certified: Addressing the patient's need for better osseointegration and less inflammatory reactions. Surface modification technology for better clinical results. Evidence based: MBT is a golden standard technology for spinal fusion, dental applications and CMF implant.
- FinMatch — FinMatch connects medium-sized companies jointly with selected financing partners and provides corporate finance and financial solutions.
They are a group of friends and internet/tech entrepreneurs who first met ten years ago in Saarbruecker Strasse 21 in Berlin Prenzlauer Berg. All of them started successful businesses, they are founders and share a passion for building great companies. As active business angels, they also invest in young startups, either individually orcollectively as a group. They provide seed funding for killer-founders and great ideas. But way more important: they help to avoid mistakes that they have already made . They introduce to the right people. They provide with all the experience that they have. Not just talking about it but helping hands-on.
Show more
Investment focus
- Software, Internet, E-Commerce
- Seed, Pre-Seed, Angel
- Germany, United States, Israel
Portfolio highlights
- Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
- a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
- Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
SV Investment Corp is a venture capital firm that provides companies with finance, strategic advice and information at critical stages of their development.
Show more
Investment focus
- Software, Information Technology, Medical
- Series A, Series B, Seed
- South Korea, United States, Germany
Portfolio highlights
- MetisX — MetisX is a startup firm that develops intelligent memory and memory-centric computing architectures based on CXL.
- AGL — AGL Co., Ltd. is a leading company that specializes in providing integrated solutions, including tee time Global Distribution System (GDS), Pay, and ERP, to both domestic and overseas golf courses.
- Avelos Therapeutics — Avelos Therapeutics is a precision medicine company in the clinical stage that finds, creates, and sells targeted therapeutics.
Groupe Arnault SAS is a principal investment firm. The firm seeks to hold stake in companies and is owned and controlled by Mr. Bernard Arnault. Groupe Arnault SAS was founded in 1978 and is based in Paris, France.
Show more
Investment focus
- Internet, E-Commerce, Health Care
- Series C, Series A, Series B
- United States, Germany, France
Portfolio highlights
Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- planqc — planqc quantum computers store information in individual atoms – nature's best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc unique combination of quantum technologies is the fastest way to scale to thousands of qubits, aprerequisite for industry-relevant quantum advantage.
- Prewave — Supplier monitoring for purchasing, supply chain management and sustainability managers.
- forward earth — Next-Gen carbon management for a sustainable future. AI-driven, automated, compliant, fast, and secure. Be prepared for requirements of CSRD, SFRD, EU-Taxonomy, and kick-start your carbon reduction and abatement program. White-label options for partners.
Over the past two decades, GFC have backed over five hundred entrepreneurs worldwide, e.g. Facebook, LinkedIn, Slack, and Away Travel.
Show more
Investment focus
- Financial Services, Software, FinTech
- Seed, Series A, Pre-Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Carv.com — Carv's AI recruiting platform is designed to take over repetitive admin tasks related to intakes and interviews, for a renewed focus on the candidate.
- Elevate Pay — Bloom mobile banking app helps in money transfer in Sudan.
- Amica Finance — Jupiter's consumer-focused neo-banking startup Amica Finance operates as an NBFC non-banking finance company.
Initiative for Industrial Innovators aim at funding up to 2,000 disruptive deep tech solutions until 2024 through our fast funding instruments. The Initiative for Industrial Innovators enables local ecosystems, each consisting of a local multi-generational Family Office, a local innovation center, and a local technical university, to join forces.
Show more
Investment focus
- Software, Medical, Health Care
- Seed, Pre-Seed, Series A
- Germany
Portfolio highlights
Mission With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions. Located in the …
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series C, Series A
- Germany, Switzerland, France
Portfolio highlights
- MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
- Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
- Simulands — Human grade cardiovascular simulators
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, The Netherlands
Portfolio highlights
- Rohlik — Rohlik is an innovative grocery delivery startup that offers a 90-minute same-day delivery service. Since its inception, Rohlik has been growing and is on track to EUR 300 mil. revenues in 2020. Rohlík was founded in 2014 by Marek Sacha and Tomas Cupr and is headquartered in Karlín, Hlavni mesto Praha, Czech Republic.
- Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
- ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
Investors by industry
Climate
Community
Gaming
Energy
FinTech
Impact
Biotech
Media (entertainment)
Hardware
Proptech
Marketplace
Artificial intelligence
Consumer
Health Care
EdTech
Sustainability
Agriculture (agtech)
Venture Capital
Photography
B2B
Infrastructure
Education
Food and Beverage
Payments
Video Games
Retail
Fashion
Finance
Publishing
Clean Energy
Financial Services
Big Data
Web3
Beauty
Oil and Gas
Real Estate
Organic Food
Medical
Social Network
Wellness
Android
Social Media
Digital Media
Google
Mobile
Franchise
Music
Sports
Facebook
Legal
eSports
Local
Construction
Email
Travel
Enterprise Software
Recruiting
Cannabis
Internet
Biotechnology
Fitness
Platforms
Hospitality
Mobile Advertising
Art
Medical Device
Manufacturing
Automotive
Wine And Spirits
CleanTech
Crowdfunding
Transportation
Social
Mobile Apps
InsurTech
Enterprise
LGBT
Non Profit
Theatre
Film
Life Science
SaaS
Renewable Energy
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Blockchain
Investors by country
South Korea
New Zealand
Germany
Ireland
United States
Australia
India
United Kingdom
Canada
Japan
Vietnam
Sri Lanka
China
Saudi Arabia
Middle East
Africa
Oceania
Asia
Europe
Indonesia
Singapore
Spain
Armenia
LATAM
Brazil
Qatar
South Africa
Georgia
Bahrain
Belize
Ethiopia
Bermuda
Chile
Costa Rica
France
Estonia
Ghana
Denmark
Belarus
Czech Republic
Ecuador
Kenya
Mexico
Egypt
Morocco
Kazakhstan
Panama
Croatia
Kuwait
Cayman Islands
Liberia
Malta
Jersey
Liechtenstein
Norway
Peru
Israel
Malaysia
Finland
Mauritius
Lithuania
Mali
Philippines
Nicaragua
Hong Kong
Cambodia
Lebanon
Myanmar
Italy
Portugal
Thailand
Algeria
Slovenia
Serbia
Sierra Leone
Rwanda
Poland
San Marino
Gibraltar
Zimbabwe
Turkey
Seychelles
Tanzania
Sweden
Faroe Islands
Greece
Puerto Rico
Taiwan
Uruguay
Senegal
Hungary
Venezuela
El Salvador
Zambia
Tunisia
Uzbekistan
Uganda
Russian Federation
Togo
Ukraine
Barbados
Belgium
Tajikistan
Dominican Republic
Bulgaria
Azerbaijan
Bahamas
Nigeria
Namibia
Iraq
Iceland
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Pakistan
Bangladesh
Albania
Argentina
Romania
Jordan
Grenada
Austria
Oman
Cyprus
Latvia
Switzerland
Cameroon
Colombia
Marshall Islands
Guatemala
VC Funds in Germany by industry
FinTech
Enterprise
Health Care
Consumer
Biotech
Climate
Sustainability
SaaS
Marketplace
Community
Artificial intelligence
Hardware
Agriculture (agtech)
Media (entertainment)
Energy
Venture Capital
Crowdfunding
Restaurants
Real Estate
Fashion
Mobile Apps
Financial Services
Cryptocurrency
Finance
Payments
Education
Food and Beverage
Video Games
Wine And Spirits
Medical
Organic Food
Email
Social Network
Medical Device
Wellness
Social Media
Music
Manufacturing
Art
Blockchain
Digital Media
Mobile
Android
Construction
Local
Legal
Enterprise Software
Sports
eSports
Fitness
Travel
InsurTech
Hospitality
Automotive
Mobile Advertising
Recruiting
Platforms
Retail
Cannabis
Biotechnology
Infrastructure
Beauty
Web3
B2B
Life Science
Big Data
Sporting Goods
Renewable Energy
Publishing
Photography
Clean Energy
Oil and Gas
CleanTech
EdTech
Impact
Social Impact
Social
Proptech
Internet
Transportation
Software
Gaming